TrivarX Limited (ASX:TRI)

Market Cap	9.23M +24.1%
Revenue (ttm)	n/a
Net Income	-8.76M
EPS	-0.01
Shares Out	1.15B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,590,040
Open	0.0080
Previous Close	0.0090
Day's Range	0.0080 - 0.0080
52-Week Range	0.0080 - 0.0310
Beta	1.04
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 24, 2026

About TrivarX

TrivarX Limited, a biotechnology company, engages in the development of AI-driven, and scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. It is also involved in research, development, and commercialisation of diagnostic and pharmaceutical products. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023. TrivarX Limited was incorporated in 1987 and is based in Hawthorn East, Australia.

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1987
• Employees: 6
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: TRI

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 20, 2026

Data Sources Report a data error